Related references
Note: Only part of the references are listed.Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance
Maria Serena Piccinno et al.
APOPTOSIS (2013)
Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells
Xiucheng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Philippe Bourin et al.
CYTOTHERAPY (2013)
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells
Sabino Ciavarella et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Sarcomas as a mise en abyme of mesenchymal stem cells: Exploiting interrelationships for cell mediated anticancer therapy
Jorge S. Burns et al.
CANCER LETTERS (2012)
Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow-Derived Stroma
Shannon Kidd et al.
PLOS ONE (2012)
TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo
L. P. Mueller et al.
CANCER GENE THERAPY (2011)
Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation
Myung-Hee Moon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro
Helga Barti-Juhasz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
Ann H. Klopp et al.
STEM CELLS (2011)
Evidence that tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits angiogenesis by inducing vascular endothelial cell apoptosis
Pei-Lin Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
Giulia Grisendi et al.
CANCER RESEARCH (2010)
Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
Gaelle Picarda et al.
CLINICAL CANCER RESEARCH (2010)
Benign Mesenchymal Stromal Cells in Human Sarcomas
Alexei Morozov et al.
CLINICAL CANCER RESEARCH (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Quantification of Rapid Myosin Regulatory Light Chain Phosphorylation Using High-Throughput In-Cell Western Assays: Comparison to Western Immunoblots
Hector N. Aguilar et al.
PLOS ONE (2010)
A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR
Bin Ren et al.
CANCER RESEARCH (2009)
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
White Adipose Tissue Cells Are Recruited by Experimental Tumors and Promote Cancer Progression in Mouse Models
Yan Zhang et al.
CANCER RESEARCH (2009)
Ewing's sarcoma origin: from duel to duality
Nicolo Riggi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin
X. Wan et al.
ONCOGENE (2009)
Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
Andrea Mohr et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL)
Avi Ashkenazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy
Lucia Kucerova et al.
CANCER RESEARCH (2007)
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand
Carmelo Carlo-Stella et al.
HUMAN GENE THERAPY (2006)
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells
G. Cantarella et al.
BRITISH JOURNAL OF CANCER (2006)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Aarif Y. Khakoo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Role of osteoprotegerin (OPG) in cancer
I Holen et al.
CLINICAL SCIENCE (2006)
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
BZ Carter et al.
BLOOD (2005)
Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells
TY Lin et al.
ONCOGENE (2002)
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRIAL-induced apoptosis
A Evdokiou et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis
HU Kontny et al.
CELL DEATH AND DIFFERENTIATION (2001)
Cytotoxicity of tumor necrosis factor related apoptosis-inducing ligand towards Ewing's sarcoma cell lines
A Kumar et al.
ONCOGENE (2001)
Share Paper
